Zytiga Superior to Provenge

The effects of taking Zytiga are far more pronounced and tangible than with the treatment Provenge. There is little evidence that Provenge even works at all and in many men who have undergone this treatment their PSA continues to rise. Independent testimonials on the benefits of Provenge are hard to find and even the manufacturers promotional video testimonials show no evidence of declining PSA following treatment. Zytiga on the other hand rapidly induces total androgen blockade in all prostate cancer patients. Some respond really well to this blockade and see their PSA rapidly fall from over 1000 to 100 within a month. So Zytiga offers real tangible benefits to prostate cancer patients that result in decreased bone pain from the cancer and a reduction in bone metastases, while all Provenge seems to offer is hype from the stock exchangers with vested interests in the Dendreon Corporation that manufactures Provenge.